Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

Cell
Lars M IttnerJürgen Götz

Abstract

Alzheimer's disease (AD) is characterized by amyloid-beta (Abeta) and tau deposition in brain. It has emerged that Abeta toxicity is tau dependent, although mechanistically this link remains unclear. Here, we show that tau, known as axonal protein, has a dendritic function in postsynaptic targeting of the Src kinase Fyn, a substrate of which is the NMDA receptor (NR). Missorting of tau in transgenic mice expressing truncated tau (Deltatau) and absence of tau in tau(-/-) mice both disrupt postsynaptic targeting of Fyn. This uncouples NR-mediated excitotoxicity and hence mitigates Abeta toxicity. Deltatau expression and tau deficiency prevent memory deficits and improve survival in Abeta-forming APP23 mice, a model of AD. These deficits are also fully rescued with a peptide that uncouples the Fyn-mediated interaction of NR and PSD-95 in vivo. Our findings suggest that this dendritic role of tau confers Abeta toxicity at the postsynapse with direct implications for pathogenesis and treatment of AD.

References

May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M D WeingartenM W Kirschner
Oct 1, 1992·Molecular Biology of the Cell·D N DrechselM W Kirschner
Nov 1, 1991·The Journal of Cell Biology·K A Butner, M W Kirschner
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P LambertW L Klein
Oct 31, 1998·Nature·M E CalhounM Jucker
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·T TezukaT Yamamoto
May 11, 2000·Acta Neuropathologica·A ProbstM Goedert
Oct 3, 2000·The Journal of Biological Chemistry·J GötzR M Nitsch
Jan 3, 2001·Nature Neuroscience·K L TuckerY A Barde
Jul 31, 2001·Nature Neuroscience·K W RocheR J Wenthold
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mark RapoportAdriana Ferreira
Oct 26, 2002·Science·Dennis J Selkoe
Dec 25, 2002·Neurobiology of Aging·P H KellyB Sommer
Jan 25, 2003·The European Journal of Neuroscience·Debby Van DamPeter P De Deyn
Mar 23, 2004·Nature Reviews. Neuroscience·Michael W Salter, Lorraine V Kalia
May 14, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeannie ChinLennart Mucke
Sep 21, 2004·Nature Reviews. Neuroscience·Eunjoon Kim, Morgan Sheng
Dec 25, 2004·Behavioural Brain Research·R LalondeC Strazielle
Oct 6, 2005·Neuron·Barbara Calabrese, Shelley Halpain
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeannie ChinLennart Mucke
Jun 5, 2007·Nature Protocols·Lars M Ittner, Jürgen Götz
Aug 9, 2007·Nature Reviews. Neuroscience·Carlo BallatoreJohn Q Trojanowski
Sep 1, 2007·The New England Journal of Medicine·Karen H Ashe

❮ Previous
Next ❯

Citations

Apr 25, 2012·Archives of Neurology·Rahul S DesikanUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 28, 2011·Cellular and Molecular Life Sciences : CMLS·Jürgen GötzXin Liu
Nov 8, 2012·Cellular and Molecular Life Sciences : CMLS·Dong WangP Robin Hiesinger
May 12, 2011·Journal of Molecular Neuroscience : MN·John C O'LearyChad A Dickey
Jul 2, 2011·Journal of Molecular Neuroscience : MN·Nicole SchonrockJürgen Götz
Mar 23, 2011·Molecular Neurobiology·Daniel W WessonDonald A Wilson
May 21, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah L DeVos, Timothy M Miller
Mar 27, 2013·Ageing Research Reviews·Johanna L CriminsTara L Spires-Jones
Oct 1, 2013·Neuropharmacology·Amy M PoolerDiane P Hanger
May 21, 2013·Lancet Neurology·Maria Grazia Spillantini, Michel Goedert
Sep 9, 2011·Nature Medicine·Dennis J Selkoe
Jan 31, 2012·Nature Neuroscience·Iryna BenilovaBart De Strooper
Jul 24, 2012·Nature Neuroscience·Ji Won UmStephen M Strittmatter
Oct 22, 2011·Nature Reviews. Drug Discovery·Dagmar E EhrnhoeferMichael R Hayden
Nov 6, 2012·Nature Reviews. Drug Discovery·Anne CorbettClive Ballard
Apr 14, 2011·Nature Reviews. Neurology·Naomi KouriDennis W Dickson
Jan 24, 2012·Seminars in Neurology·Henry L Paulson, Indu Igo
Mar 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ming JinDennis J Selkoe
Feb 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anders BachKristian Strømgaard
Jun 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Maria TalantovaStuart A Lipton
Oct 11, 2011·The Journal of Biological Chemistry·Elena TortosaJesús Avila
Jan 12, 2012·The Journal of Biological Chemistry·Niko-Petteri NykänenHenri J Huttunen
Jul 27, 2012·The Journal of Biological Chemistry·Siddhartha Mondragón-RodríguezJannic Boehm
Nov 30, 2011·Antioxidants & Redox Signaling·Rommy von Bernhardi, Jaime Eugenín
Nov 29, 2011·Antioxidants & Redox Signaling·Karen SchmittAnne Eckert
Apr 12, 2013·Brain : a Journal of Neurology·Sylvain E LesnéKaren H Ashe
Dec 24, 2011·Human Molecular Genetics·Tamar SapirOrly Reiner
Mar 16, 2013·Current Opinion in Psychiatry·Perminder S SachdevWei Wen
Dec 4, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Tetsuya KimuraKwangwook Cho
Nov 30, 2011·TheScientificWorldJournal·Kurt A Jellinger
Apr 12, 2012·Cold Spring Harbor Perspectives in Biology·Morgan ShengThomas C Südhof
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eva-Maria Mandelkow, Eckhard Mandelkow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.